The role of leukotriene B4 in Clostridium difficile toxin A-induced ileitis in rats

Gastroenterology

Volumn 128, Issue 5, 2005, Pages 1306-1316

  McVey, Douglas C ^a   Vigna, Steven R ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,6 DIHYDROXYHEXYL) 6 (3 HYDROXY 1,5 UNDECADIENYL)PYRIDINE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; ARACHIDONATE 5 LIPOXYGENASE; CAPSAZEPINE; CLOSTRIDIUM DIFFICILE TOXIN A; LEUKOTRIENE B4; MYELOPEROXIDASE; SUBSTANCE P; SUBSTANCE P ANTAGONIST; VANILLOID RECEPTOR 1; BACTERIAL TOXIN; ENTEROTOXIN; ION CHANNEL; TCDA PROTEIN, CLOSTRIDIUM DIFFICILE; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SYNTHESIS; HISTOLOGY; HYPOTHESIS; ILEITIS; ILEUM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; ANIMAL; DOSE RESPONSE; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; PSEUDOMEMBRANOUS COLITIS; SPRAGUE DAWLEY RAT;

ANIMALS; BACTERIAL TOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENTEROCOLITIS, PSEUDOMEMBRANOUS; ENTEROTOXINS; ILEITIS; ION CHANNELS; LEUKOTRIENE B4; MALE; RATS; RATS, SPRAGUE-DAWLEY; TRPV CATION CHANNELS;

EID: 19044386605     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2005.03.017     Document Type: Article

References (48)

1. C. Pothoulakis Pathogenesis of Clostridium difficile-associated diarrhoea Eur J Gastroenterol Hepatol 8 1996 1041 1047
2. C. Pothoulakis, J.T. LaMont Microbes and microbial toxins: paradigms for microbial-mucosal interactions II. The integrated response of the intestine to Clostridium difficile toxins Am J Physiol 280 2001 G178 G183
3. P. Geppetti, P. Holzer Neurogenic inflammation 1996 CRC Press Boca Raton
4. D.C. McVey, S.R. Vigna The capsaicin VR1 receptor mediates substance P release in toxin A-induced enteritis in rats Peptides 22 2001 1439 1446
5. D.C. McVey, P.C. Schmid, H.H.O. Schmid, S.R. Vigna Endocannabinoids induce ileitis in rats via the capsaicin receptor (VR1) J Pharmacol Exp Ther 304 2003 713 722
6. R. Eglow, C. Pothoulakis, S. Itzkowitz, E.J. Israel, C.J. O'Keane, D. Gong, N. Gao, Y.L. Xu, W.A. Walker, J.T. LaMont Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor J Clin Invest 90 1992 822 829
7. J. Torres, E. Jennische, S. Lange, I. Lönnroth Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine Gut 31 1990 781 785
8. C. Pothoulakis, I. Castagliuolo, J.T. LaMont Nerves and intestinal mast cells modulate responses to enterotoxins News Physiol Sci 13 1998 58 63
9. S.M. Ward, J. Bayguinov, K.-J. Won, D. Grundy, H.R. Berthoud Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract J Comp Neurol 465 2003 121 135
10. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, V. Di Marzo, D. Julius, D. Högestätt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457
11. S.W. Hwang, H. Cho, J. Kwak, S.-Y. Lee, C.-J. Kang, J. Jung, S. Cho, K.H. Min, Y.-G. Suh, D. Kim, U. Oh Direct activation of capsaicin receptors by products of lipoxygenases endogenous capsaicin-like substances Proc Natl Acad Sci U S A 97 2000 6155 6160
12. 1 receptor Proc Natl Acad Sci U S A 98 2002 3662 3665
13. S.M. Huang, T. Bisogno, M. Trevisani, A. Al-Hayani, L. De Petrocellis, F. Fezza, M. Tognetto, T.J. Petros, J.F. Krey, C.J. Chu, J.D. Miller, S.N. Davies, P. Geppetti, J.M. Walker, V. Di Marzo An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors Proc Natl Acad Sci U S A 99 2002 8400 8405
14. W.F. Stenson Role of eicosanoids as mediators of inflammation in inflammatory bowel disease Scand J Gastroenterol 172 Suppl 1990 13 18
15. 4 by colonic mucosa in inflammatory bowel disease Gastroenterology 86 1984 453 460
16. 4 Dig Dis Sci 32 1987 1380 1388
17. W.F. Stenson, E. Lobos Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils J Clin Invest 69 1982 494 497
18. P. Sharon, W.F. Stenson Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease Gastroenterology 88 1985 55 63
19. J.L. Wallace, W.K. MacNaughton, G.P. Morris, P.L. Beck Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease Gastroenterology 96 1989 29 36
20. 4 in rabbit colitis. Relationship to inflammation Gastroenterology 92 1987 33 39
21. J.L. Wallace, C.M. Keenan An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis Am J Physiol 258 1990 G527 G534
22. C. Pothoulakis, I. Castagliuolo, J.T. LaMont, A. Jaffer, J.C. O'Keane, R.M. Snider, S.E. Leeman CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin Proc Natl Acad Sci U S A 91 1994 947 951
23. C.R. Mantyh, T.N. Pappas, J.A. Lapp, M.K. Washington, L.M. Neville, J.R. Ghilardi, S.D. Rogers, P.W. Mantyh, S.R. Vigna Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum Gastroenterology 111 1996 1272 1280
24. R.C. Falcone, D. Aharony Modulation of ligand binding to leukotriene B4 receptors on guinea pig lung membranes by sulfhydryl modifying reagents J Pharmacol Exp Ther 255 1990 565 571
25. P.P. Bradley, D.A. Priebat, R.D. Christensen, G. Rothstein Measurement of cutaneous inflammation estimation of neutrophil content with an enzyme marker J Invest Dermatol 78 1982 206 209
26. S.R. Vigna, J.J. Bowden, D.M. McDonald, J. Fisher, A. Okamoto, D.C. McVey, D.G. Payan, N.W. Bunnett Characterization of antibodies to the rat substance P (NK- 1) receptor and to a chimeric substance P receptor expressed in mammalian cells J Neurosci 14 1994 834 845
27. P.W. Mantyh, E. Demaster, A. Malhotra, J.R. Ghilardi, S.D. Rogers, C.R. Mantyh, H. Liu, A.I. Basbaum, S.R. Vigna, J.E. Maggio, D.A. Simone Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation Science 268 1995 1629 1632
28. B. Zingarelli, F. Squadrito, P. Graziani, R. Camerini, A.P. Caputi Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats Agents Actions 39 1993 150 156
29. A. Toda, T. Yokomizo, T. Shimizu Leukotriene B4 receptors Prostaglandins Other Lipid Mediat 68-69 2002 575 585
30. 4 receptor antagonist, SC-53228 effects on acute colonic inflammation and hepatic function in rodents Inflammation 19 1995 503 515
31. T. Ten Hove, P. Drillenburg, J. Wijnholds, A. Te Velde, S.J.H. Van Deventer Differential susceptibility of multidrug resistance protein-1 deficient mice to DSS and TNBS-induced colitis Dig Dis Sci 47 2002 2056 2063
32. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, D. Julius The capsaicin receptor a heat-activated ion channel in the pain pathway Nature 389 1997 816 824
33. P. Holzer Local effector functions of capsaicin-sensitive sensory nerve endings involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides Neuroscience 24 1988 739 768
34. R.J. Docherty, J.C. Yeats, A.S. Piper Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture Br J Pharmacol 121 1997 1461 1467
35. L. Liu, S.A. Simon Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia Neurosci Lett 228 1997 29 32
36. A. Szallasi, P.M. Blumberg Vanilloid (capsaicin) receptors and mechanisms Pharmacol Rev 51 1999 159 211
37. P. Wahl, S. Foged, S. Tullin, C. Thomsen Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist Mol Pharmacol 59 2001 9 15
38. G.R. Seabrook, K.G. Sutton, W. Jarolimek, G.J. Hollingworth, S. Teague, J. Webb, N. Clark, S. Boyce, J. Kerby, Z. Ali, M. Chou, R. Middleton, G. Kaczorowski, A.B. Jones Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin J Pharmacol Exp Ther 303 2002 1052 1060
39. B.R. Southwell, H.L. Woodman, R. Murphy, S.J. Royal, J.B. Furness Characterisation of substance P-induced endocytosis of NK1 receptors on enteric neurons Histochem Cell Biol 106 1996 563 571
40. J.C.G. Marvisón, X. Wang, Y. Matsuka, J.K. Neubert, I. Spigelman Relationship between capsaicin-evoked substance P release and neurokinin 1 receptor internalization in the rat spinal cord Neuroscience 118 2003 535 545
41. 1) antagonists Trends Pharmacol Sci 20 1999 485 490
42. M. Luo, S. Lee, T.G. Brock Leukotriene synthesis by epithelial cells Histol Histopathol 18 2003 587 595
43. 4 synthesis in the human intestinal cell (CaCo-2) Gut 33 1992 622 627
44. A. Sjolander, A. Schippert, S. Hammarstrom A human epithelial cell line, intestine 407, can produce 5-hydroxyeicosatetraenoic acid and leukotriene B4 Prostaglandins 45 1993 85 96
45. J.F. Cortese, E.W. Spannhake, W. Eisinger, J.J. Potter, V.W. Yang The 5-lipoxygenase pathway in cultured human intestinal epithelial cells Prostaglandins 49 1995 155 166
46. S. Battu, G. Clement, M. Heyman, J.M. Wal, J. Cook-Moreau, J.F. Desjeux, J.L. Beneytout Production of arachidonic acid metabolites by the colon adenocarcinoma cell line HT29 cl.19A and their effect on chloride secretion Cancer Lett 116 1997 213 223
47. 2 inhibitor Am J Physiol 285 2003 G586 G592
48. J. Rask-Madsen, K. Bukhave, L.S. Laursen, K. Lauritsen 5-lipoxygenase inhibitors for the treatment of inflammatory bowel disease Agents Actions 1992 C37 C46 (Special Conference Issue):